The Board of Directors of Buzzi Unicem, which met today, resolved the issue of a benchmark bond in euro, (amount of 300-400 million), with minimum denomination of €50,000 to be placed with institutional investors only. The amount and the price of the offering will be defined based on market conditions. Buzzi plans to apply for the listing of the bond and the admission to trading on the Luxembourg regulated market (Luxembourg Stock Exchange). Through the forthcoming issue, the company aims at diversifying the funding sources and lenghtening the average debt maturity profile.
Banca IMI and Deutsche Bank will act as Joint Lead Manager and Joint Bookrunner of the transaction.
The notes will only be offered and sold outside the United States to institutional investors that are non-U.S. persons under Regulation S and have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) or any other securities laws. The notes may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This press release shall not constitute an offer to sell or an offer of financial products, nor shall there be any sale of these notes in any state or Jurisdiction in which such an offer or sale would be unlawful. No action has been or will be taken to permit a public offering of the notes in any jurisdiction, including Italy.
This press release is not an offer of securities for sale or an offer of financial products in the Unites States or in any other jurisdiction, including Italy. The securities may not be offered or sold in the United States or to or for the account or benefit of U.S. persons (as such term is defined in Regulation S of the U.S. Securities Act) unless registered under the U.S. Securities Act of 1933 or pursuant to an exemption from such registration. Any offer of securities will be made by means of a prospectus that will contain detailed information on, inter alia, Buzzi Unicem and its management.
Not for distribution in the United States
Investor Relations Assistant
Phone +39 0142 416 404